Posts Tagged ‘IVGN’

Downward Volume Surge: Invitrogen (IVGN, ABI)

Invitrogen Corp. (NASDAQ: IVGN) is seeing a surge in trading volume this morning, and the reason is a $6.7 Billion acquisition of Applera’s Applied Biosystems Group (NYSE: ABI). We have already seen over 650,000 shares trade hands at 9:20 AM EST and the average daily volume is 1.3 million shares. Shares are down right around [...]